LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR).

    Kaufman, Nichole E M / Dhingra, Simran / Jois, Seetharama D / Vicente, Maria da Graça H

    Molecules (Basel, Switzerland)

    2021  Volume 26, Issue 4

    Abstract: Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are two extensively studied membrane-bound receptor tyrosine kinase proteins that are frequently overexpressed in many cancers. As a result, these receptor ... ...

    Abstract Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are two extensively studied membrane-bound receptor tyrosine kinase proteins that are frequently overexpressed in many cancers. As a result, these receptor families constitute attractive targets for imaging and therapeutic applications in the detection and treatment of cancer. This review explores the dynamic structure and structure-function relationships of these two growth factor receptors and their significance as it relates to theranostics of cancer, followed by some of the common inhibition modalities frequently employed to target EGFR and VEGFR, such as tyrosine kinase inhibitors (TKIs), antibodies, nanobodies, and peptides. A summary of the recent advances in molecular imaging techniques, including positron emission tomography (PET), single-photon emission computerized tomography (SPECT), computed tomography (CT), magnetic resonance imaging (MRI), and optical imaging (OI), and in particular, near-IR fluorescence imaging using tetrapyrrolic-based fluorophores, concludes this review.
    MeSH term(s) Animals ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Humans ; Molecular Imaging ; Molecular Targeted Therapy ; Peptides/chemistry ; Peptides/pharmacology ; Protein Multimerization ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Receptors, Vascular Endothelial Growth Factor/chemistry ; Receptors, Vascular Endothelial Growth Factor/metabolism
    Chemical Substances Peptides ; ErbB Receptors (EC 2.7.10.1) ; Receptors, Vascular Endothelial Growth Factor (EC 2.7.10.1)
    Language English
    Publishing date 2021-02-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1413402-0
    ISSN 1420-3049 ; 1431-5165 ; 1420-3049
    ISSN (online) 1420-3049
    ISSN 1431-5165 ; 1420-3049
    DOI 10.3390/molecules26041076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A Comparison of the Photophysical, Electrochemical and Cytotoxic Properties of

    Ndung'u, Caroline / LaMaster, Daniel J / Dhingra, Simran / Mitchell, Nathan H / Bobadova-Parvanova, Petia / Fronczek, Frank R / Elgrishi, Noémie / Vicente, Maria da Graça H

    Sensors (Basel, Switzerland)

    2022  Volume 22, Issue 14

    Abstract: Boron dipyrromethene (BODIPY) dyes bearing a pyridyl moiety have been used as metal ion sensors, pH sensors, fluorescence probes, and as sensitizers for phototherapy. A comparative study of the properties of the three structural isomers ... ...

    Abstract Boron dipyrromethene (BODIPY) dyes bearing a pyridyl moiety have been used as metal ion sensors, pH sensors, fluorescence probes, and as sensitizers for phototherapy. A comparative study of the properties of the three structural isomers of
    MeSH term(s) Boron Compounds/chemistry ; Boron Compounds/toxicity ; Humans ; Molecular Structure ; Solvents/chemistry ; Water
    Chemical Substances 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene ; Boron Compounds ; Solvents ; Water (059QF0KO0R)
    Language English
    Publishing date 2022-07-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2052857-7
    ISSN 1424-8220 ; 1424-8220
    ISSN (online) 1424-8220
    ISSN 1424-8220
    DOI 10.3390/s22145121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant.

    Kaushik, Deepender / Dhingra, Simran / Patil, Madhuri T / Piplani, Sakshi / Khanna, Varun / Honda-Okubo, Yoshikazu / Li, Lei / Fung, Johnson / Sakala, Isaac G / Salunke, Deepak B / Petrovsky, Nikolai

    Human vaccines & immunotherapeutics

    2020  Volume 16, Issue 8, Page(s) 1989–1996

    Abstract: Better adjuvants are needed for vaccines against seasonal influenza. TLR7 agonists are potent activators of innate immune responses and thereby may be promising adjuvants. Among the imidazoquinoline compounds, 1-benzyl-2-butyl-1H-imidazo[4,5-c]quinolin-4- ...

    Abstract Better adjuvants are needed for vaccines against seasonal influenza. TLR7 agonists are potent activators of innate immune responses and thereby may be promising adjuvants. Among the imidazoquinoline compounds, 1-benzyl-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine (BBIQ) was reported to be a highly active TLR7 agonist but has remained relatively unexplored because of its commercial unavailability. Indeed,
    MeSH term(s) Adjuvants, Immunologic ; Animals ; Imiquimod ; Influenza Vaccines ; Influenza, Human/prevention & control ; Mice ; Toll-Like Receptor 7
    Chemical Substances Adjuvants, Immunologic ; Influenza Vaccines ; Toll-Like Receptor 7 ; Imiquimod (P1QW714R7M)
    Keywords covid19
    Language English
    Publishing date 2020-04-16
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2664176-8
    ISSN 2164-554X ; 2164-5515
    ISSN (online) 2164-554X
    ISSN 2164-5515
    DOI 10.1080/21645515.2019.1710409
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top